- FDA appears to be slow-walking vaccine approvals NBC News
- FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots AP News
- U.S. health officials inject new uncertainty into approval process for Covid boosters statnews.com
- Exclusive | FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot WSJ
- Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. Barron’s